12 results
Validation of the Step-By-Step Approach to Febrile Infants

#Diagnosis #Management #Pediatrics #Peds #Febrile #Infant #StepByStep #Algorithm #LP
Approach to Febrile Infants ... Management #Pediatrics #Peds ... #Febrile #Infant ... #StepByStep #Algorithm ... Antibiotics #Risk #Stratification
Validation of the “Step-by-Step” Approach in the Management of Young Febrile Infants
Visual Abstract by Dr. Kirsty
Young Febrile Infants ... 27382134 #EBM #Peds ... VisualAbstract #StepByStep #Algorithm ... #Febrile #Infant ... #Risk #Stratification
Causes of Sudden Unexpected Death in Infancy (SUDI) - Differential Diagnosis Algorithm
Congenital Anomaly / Disorder:
 •
Unexpected Death in Infancy ... Differential Diagnosis Algorithm ... Neurologic Anomaly • Pulmonary ... #Diagnosis #Algorithm ... #Causes #Peds #
“Step by Step” – the new kid on the block – aims to risk stratify this
investigations and treatments ... Procalcitonin <0.5 ng/mL ... Management #Pediatrics #Peds ... #Febrile #Infant ... Antibiotics #Risk #Stratification
Step by Step Algorithmic Approach to Pediatric Fever

Age < 21 days old (or 28 days for
Step by Step Algorithmic ... Procalcitonin >= 0.5 ng/mL ... #Pediatrics #Peds ... Management #StepByStep #Algorithm ... #Infant #Fever
The Febrile Infant Step-by-Step Algorithm
This is an algorithm developed by European emergency physicians to identify low-risk
The Febrile Infant ... This is an algorithm ... empiric antibiotic treatment ... Management #Pediatrics #Peds ... Antibiotics #Risk #Stratification
Pediatric SVT - Management Algorithm
Identify SVT:
 • HR not variable
 • Abrupt rate changes
 • Infants:
SVT - Management Algorithm ... rate changes • Infants ... tachycardia #Management #Algorithm ... #peds #Pediatric ... #treatment
Causes of Pediatric Stridor - Differential Diagnosis Algorithm
Present Since Infancy with No Respiratory Distress:
 • Laryngomalacia
Present
Differential Diagnosis Algorithm ... Present Since Infancy ... Present Since Infancy ... #Causes #Peds # ... Pediatrics #Pulmonary
Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc)

Therapeutic indication: absolute decline in FVC >10%
>10% (or >200 mL ... DLCO >15% (or 3 mL ... Symptomatic treatment ... systemicsclerosis #SSc #pulmonary ... #algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the ... treatment of cancer-associated ... thrombosis; PE = pulmonary ... Malignancy #Cancer #Algorithm